var data={"title":"Society guideline links: Chronic kidney disease in adults","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Society guideline links: Chronic kidney disease in adults</div><p class=\"disclosureLink\"></p><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1734429721\"><span class=\"h1\">Introduction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.</p><p>The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.</p><p>Links to related guidelines are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-chronic-kidney-disease-in-children\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Chronic kidney disease in children&quot;</a> and <a href=\"topic.htm?path=society-guideline-links-anemia-in-chronic-kidney-disease\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Anemia in chronic kidney disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H934096855\"><span class=\"h1\">International</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.sciencedirect.com/science/article/pii/S2157171615322772&amp;token=kfDaku7Z+KfeT5fgXqtcyMn0Pz2Hqdpq6bC8AyA/9SYDjnqbtF0zXz3UYFTG93rXjMOyvuXLs7vFooXMmuDBGpU0AXvYzEC0/Bpu0k/jyDg=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Kidney Disease: Improving Global Outcomes (KDIGO): Consensus report on autosomal dominant tubulointerstitial kidney disease &ndash; Diagnosis, classification, and management</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.sciencedirect.com/science/article/pii/S0085253815560973&amp;token=kfDaku7Z+KfeT5fgXqtcyMn0Pz2Hqdpq6bC8AyA/9SYDjnqbtF0zXz3UYFTG93rXCK7tfaKtvQXKXidralHN3RBNaHkuh4uFN66OeGR0/II=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">International Society of Renal Nutrition and Metabolism (ISRNM): Consensus statement on prevention and treatment of protein energy wasting in chronic kidney disease patients</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S105122761300006X/1-s2.0-S105122761300006X-main.pdf?_tid=514c80be-2470-11e7-8d2d-00000aab0f26&acdnat=1492545227_4b2ed55c569100c10e4612161c022e6e&amp;token=+DKGmVTSfhCSEZ7RBewY/gxvQVT5cXu0QpHX4aVbLpns1p2tkjzLxZDWIlieyP6+VqvcML/GoW0CngNy3zvNEtL+hewr+yyk6oQb0wCp7DL4u2Nw+J1nAZeyj+5y/6ulEQg0FM4vbnR9tv5Gr4N4bXWs3lNBggXIp7aXOrUIzMEtN/ef5Sw7FTOfkh5mw8HW&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">ISRNM: Consensus statement on the etiology of the protein-energy wasting syndrome in chronic kidney disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://kdigo.org/wp-content/uploads/2017/02/KDIGO-2013-Lipids-Guideline-English.pdf&amp;token=EhX3jXKdUa27/BnjSXtKG2xdDfq92cPof0vCgldhks4sHBx4acHIuCw4BsPjov8X7gHAJ5GSKTTqNqp2NdZw5+z6uY+eZDPJ+Uxg3al5nD3m/YIyl+Q9TFsIXZvItIYd&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KDIGO: Clinical practice guideline for lipid management in chronic kidney disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf&amp;token=0f1YcMaJI2jpAgzbc+ecqyrbGlP2/aej3IoCF+GEP2a1cj59MSXsbg+BW0XxkT1EppWfTzSnIMpGFJE7GdGOzeXQE9P5gOh473CmYG8gqQo=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KDIGO: Clinical practice guideline for the evaluation and management of chronic kidney disease, 2012</a> (published 2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Blood-Pressure-Guideline-English.pdf&amp;token=rY6iJZ03IuhJ3Mw6kemIChedGr7Wd1h762cs2svxV38cIeuLVBCn+s6YMlH+L2RAzstQpZuczb8D5KskDf++HJmcLLhnZ1rEUMby3agtkgCqPXFNzVH6G8GdhMM/6SKS&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KDIGO: Clinical practice guideline for the management of blood pressure in chronic kidney disease</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S0085253815551193/1-s2.0-S0085253815551193-main.pdf?_tid=9e0b806e-2509-11e7-b363-00000aab0f01&acdnat=1492611069_ec7bee0293921af1772527f0b04e130d&amp;token=WiMOFQqaAWHRoo7Utl7Gm7VWEpEyATafUOXW6fGBNXHHpSYjF+MtbddFqfK8Un9+uUfQ35Aes0hWfYofiAEc14COTMqb9C+07BtNcoaLiOTM704F4HXKgrV0CWBqHmIb+gE67hIY4vy2AHio8vKS08gmHomWdVoHVBKwbhmNLrqEBOYRlwnX1BivI0z4SSvE&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">International Society of Nephrology (ISN) and International Pediatric Nephrology Association (IPNA): Consensus statement on transition from pediatric to adult renal services</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S0272638609006052/1-s2.0-S0272638609006052-main.pdf?_tid=4e58dd32-24ff-11e7-9499-00000aacb362&acdnat=1492606640_d8392d85f7c3a0a6030efe81747b8a73&amp;token=xlLE7TOm0UZnn3EJP7NXSkS2cvh8o0gLzMSxwyj9/gPweKySJuI8jsg3qlXdmEpmeh06ilDHabb1TqPhUBSdt321Go/YdYMRrZjx3VHFK1GsWveF8PubYW/WmfNj4LnaGt9u4S132fP4znzoIjRwd2mdzRDr7kN8jv3fwPulcDPFlPdySvczcPmNN+mLCyoq&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Kidney Disease Outcomes Quality Initiative (KDOQI) and KDIGO: Position statement on definition and classification of CKD &ndash; The debate should be about patient prognosis</a> (2009)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://kdigo.org/home/hepatitis-c-in-ckd/&amp;token=0f1YcMaJI2jpAgzbc+ecq5q/KASEBpLR6PNt/wI+RVB/cqg9fvF4vPvcpCoOQNsfEpyk+IU7hff1/MasBTq3Ig==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KDIGO: Clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease</a> (2008)</p><p/><p class=\"headingAnchor\" id=\"H3247897960\"><span class=\"h1\">Canada</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.carjonline.org/article/S0846-5371(12)00116-7/pdf&amp;token=A4rNrjoOj2Gkzpl8CyA25rNbtEqE8vBO5waqdgPr5pYENyfTSg8wTInC18vT+G0UV2P1Hdxpn+nflTaG4FDDwRKMrRHrt+9+VM2eXuypA1I=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Canadian Association of Radiologists (CAR): Consensus guidelines for the prevention of contrast-induced nephropathy, 2012 update</a> (published 2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.canadianjournalofdiabetes.com/article/S1499-2671(13)00038-5/pdf&amp;token=+4cBCd4hrat9fnIyIQ2cmDRxEJXPZbXfKfyXw3KqtjPMRwa0eW8J7tSV5P2gDF6Z8gcZAniHfSFZF2PGoxDfE+XSNGry4G9CWylS7xo2m+qvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Canadian Diabetes Association (CDA): Clinical practice guidelines on chronic kidney disease in diabetes</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwiselycanada.org/wp-content/uploads/2014/09/Nephrology.pdf&amp;token=6vaxJfZCuZOp8f4e81d3FhF8hG//zRzSBermgqgjeYKcDBA4E6P5e4wI+GSC3Vkft8U2S0AARPgDt41trY0O7CEC1wubGz2QACEuhU4LUiw=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely Canada: Don't initiate dialysis in outpatients with Stage 5 CKD in the absence of clinical indications</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwiselycanada.org/wp-content/uploads/2014/09/Nephrology.pdf&amp;token=6vaxJfZCuZOp8f4e81d3FhF8hG//zRzSBermgqgjeYKcDBA4E6P5e4wI+GSC3Vkft8U2S0AARPgDt41trY0O7CEC1wubGz2QACEuhU4LUiw=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely Canada: Don't initiate erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 100 g/L without symptoms of anemia</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwiselycanada.org/wp-content/uploads/2014/09/Nephrology.pdf&amp;token=6vaxJfZCuZOp8f4e81d3FhF8hG//zRzSBermgqgjeYKcDBA4E6P5e4wI+GSC3Vkft8U2S0AARPgDt41trY0O7CEC1wubGz2QACEuhU4LUiw=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely Canada: Don't prescribe nonsteroidal anti-inflammatory drugs (NSAIDs) in individuals with hypertension or heart failure or CKD of all causes, including diabetes</a> (2012)</p><p/><p class=\"headingAnchor\" id=\"H1322772545\"><span class=\"h1\">United States</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.cdc.gov/vaccines/pubs/downloads/dialysis-guide-2012.pdf&amp;token=Q8nyMQo5VCn7we43z6VO20TbDkMdilXVk575a75eP60R4GzpiIdb6wrTj+cO9chmD3udWU2zIfT439OlyRQp20BqJW5LcKs83j0Kb+7F014=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention (CDC): Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease</a> (2012, reviewed 2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.kidney.org/sites/default/files/RenalRDN_SOP_SOPP_2014JRN.pdf&amp;token=VWxlyGe2dyiG3APLLAgT16stnQJFia8p1ZGnYPjgSSl6U+Z5M6jbPAKHx0TEDH3Z/PJIlr8ma2vmQ8FBe/P1OCOmfEj0JqVbr7NORTI4RFk=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Academy of Nutrition and Dietetics (AND) and National Kidney Foundation (NKF): Revised standards of practice and standards of professional performance for registered dietician nutritionists (competent, proficient, and expert) in nephrology nutrition</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/ciu617&amp;token=EsrG99tGqpQqoviGRaK1j7DFD177bxritv6Z+ai+/NSBiKGav5Ze0BR+b38aFd05hoQ8h+xpeZZN1WYKher6LpUc6NWuTo8w2p/y4BpZZJs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Infectious Diseases Society of America (IDSA): Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV, update</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.healthquality.va.gov/guidelines/CD/ckd/VADoDCKDCPG2014.pdf&amp;token=sL+p+gWoM5K8OZ3TcR7z2WAY32Ka/u1lbC6jdvtVYpnc5sxF9OOafzGtnKXFxC2o594TT41hgtwTIhS1JBsa25KtdVbBBv04W+TpafLmC8s=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Department of Veterans Affairs (VA)/Department of Defense (DoD): Clinical practice guideline for the management of chronic kidney disease in primary care, 3rd edition</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://annals.org/aim/article/1757302/screening-monitoring-treatment-stage-1-3-chronic-kidney-disease-clinical&amp;token=r0PAqfi8tHPaTPGYNoa1O2pzXdVJk4o9BSlR9HEFlU6TCYWyDFCjCOvsbJYVzcrw6SMLQa+ZUsWTXYGAOnmP+x82yLcXXK/7uIowiN05hNXuUhVUcUJNvWFsn2xG16mf9t3ovkWwluX0wZTj1TFCSw==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">American College of Physicians (ACP): Clinical practice guideline on screening, monitoring and treatment of stage 1 to 3 chronic kidney disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://link.springer.com/article/10.1007%2Fs10897-013-9613-3&amp;token=3vrciaU7tEygqhBjxqbz3ECTrPvFYppfr0WHOx60olIuvSZwu7jz0H+3MmTArn0piUFtSFw+Pjbu0WTQ5ip5HzW4vCZfrBGbZGvJLdeGnds=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">National Society of Genetic Counselors (NSGC): Recommendations on Fabry disease practice guidelines</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://c.ymcdn.com/sites/www.asdin.org/resource/resmgr/imported/CIED+published+paper.pdf&amp;token=u2du2f81WHlQVNvTsaNubmYnY7DpvONWkCGVC+24bR4l9vpgRBgpewBINqH9u94EWRhRMYF5SP05yJd6vkR44Ql/prU588II4LYGcnhSPrY15/CpSOMif8pgndrP17L9&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">American Society of Diagnostic and Interventional Nephrology (ASDIN): Cardiovascular implantable electronic device leads in CKD and ESRD patients &ndash; Review and recommendations for practice</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-society-nephrology-nsaids-in-individuals-with-hypertension-heart-failure-or-chronic-kidney-disease/&amp;token=mO/bcHuBS87kGVrKqcSJQZj2A8RdC1gkRn2E0MA6zJSe09BcUSLdMmxIyxRsmNeg2loMFytxQMU+05+awJA705EVs1M9OQlDFqo6jvy89iexjI69bTlZQ6MufQBEf+BO30va+pdjIb5HGEFB/kiks3RWSZnv1E8VmZMSs6GQvng=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely: Avoid nonsteroidal anti-inflammatory drugs (NSAIDS) in individuals with hypertension or heart failure or CKD of all causes, including diabetes</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-society-nephrology-erythropoiesis-stimulating-agents-for-patients-with-chronic-kidney-disease/&amp;token=7EFVsQw486Zwe+FpOaGotwc9geKBKA9yEalAAzGeIzyQNHcGFzkA8JXPtLR42X5GEn/h0d6mQmsZGeOJyygpRseQRvJlhpbjyWF56pNhPWKWLcPkWmtFgs9HbEl20O1u0/fUAUEsH/r5fbPxm+lYgwkaAUof/s4wvnaFeBkrEVc=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely: Don&rsquo;t administer erythropoiesis-stimulating agents (ESAs) to chronic kidney disease (CKD) patients with hemoglobin levels greater than or equal to 10 g/dL without symptoms of anemia</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.choosingwisely.org/clinician-lists/american-society-nephrology-peripherally-inserted-central-catheters-in-stage-iii-iv-ckd-patients/&amp;token=Ou8B4AyX8WayRLwPGe3kESHZPvqTwMkG1SnJxlIbEhlm1pggAd1LaMIWO7+5P9g9j3GW5WHepcWPT3gdSqZRl/v0o+TrAxzN73dgFtubnrMRmodzu8vrMG0okLsHsCc4ziHLMQwMxm6xgbKhPV9Iqg==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely: Don&rsquo;t place peripherally inserted central catheters (PICC) in stage III-V CKD patients without consulting nephrology</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.ajkd.org/article/S0272-6386(12)00957-2/pdf&amp;token=yaP5ui3z9AjbtoKNwvA/3lOKn5rbuuwKVUzAsUkE3gxVUPYC2YSkxzpmJCdVK6cT/mQLkVj+T9YM6luLwjCzgA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NKF Kidney Disease Outcomes Quality Initiative (KDOQI): Clinical practice guideline for diabetes and CKD, update</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/chronic-kidney-disease-ckd-screening&amp;token=3sxk/JTZ14/Io52ILA+OH53WW7VW1FLgQgddyNDMOJ6Xj0jD78DLY/yU8ZvOBTfybrUe9WAuu9ULeIXje88dSM68wZliujnLB4q8ZHxy0CT6ob7Kt5uIWqfPGpnfmqU/icykSs1JTTymzZLpB9aPoA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">US Preventative Services Task Force (USPSTF): Recommendation statement on screening for chronic kidney disease &ndash; Clinical guideline</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.andeal.org/topic.cfm?menu=5303&cat=3927&amp;token=PRKPO3uO+dPuh8VYneBd1Fr3XGkW6/jPbBgAGmPNtF801gM/UEa2fCWqNAxYVchKYNEUJPt4CX2kLS4+QilLgA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">AND: Chronic kidney disease (CKD) evidence-based nutrition practice guideline</a> (2010)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://journals.sagepub.com/doi/pdf/10.1177/0148607110374577&amp;token=utw6Z8Dkpk0zZwaFP8JimOoNBILtvqH1VHMeweBsNWA9vk2eWPTe/sC/uUkJJTk6XnUdx2rnMNhbte2SWZXJiNAtPfhw5WGBQwLVPpI0Ev8=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">American Society of Parenteral and Enteral Nutrition (ASPEN): Clinical guidelines &ndash; Nutrition support in adult acute and chronic renal failure</a> (2010)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S0272638608017307/1-s2.0-S0272638608017307-main.pdf?_tid=8e5c9020-211e-11e7-9e35-00000aacb360&acdnat=1492180258_365663e442cbcb1b163282be07838b04&amp;token=3PbchkyJf00VpzxchNh095Lcq0UJHJRJ+zgEvntGXfovIc7amlD7Z/tJJo2fvWN0fxleQd1flHxt2HWDzB6uX6FQoII8d30bxvzwUOnYOn5q/uZhyWLeLnFaf7aoqlA/kqsyiNCdbZda1DWBxFQFve4hDgM9a2ltB5n1GBn8DrlMNvruA48GW/r0mcRmY+Je&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">CDC: Comprehensive public health strategies for preventing the development, progression, and complications of CKD &ndash; Report of an expert panel</a> (2009)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://ac.els-cdn.com/S0272638609006052/1-s2.0-S0272638609006052-main.pdf?_tid=4e58dd32-24ff-11e7-9499-00000aacb362&acdnat=1492606640_d8392d85f7c3a0a6030efe81747b8a73&amp;token=xlLE7TOm0UZnn3EJP7NXSkS2cvh8o0gLzMSxwyj9/gPweKySJuI8jsg3qlXdmEpmeh06ilDHabb1TqPhUBSdt321Go/YdYMRrZjx3VHFK1GsWveF8PubYW/WmfNj4LnaGt9u4S132fP4znzoIjRwd2mdzRDr7kN8jv3fwPulcDPFlPdySvczcPmNN+mLCyoq&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KDOQI and Kidney Disease: Improving Global Outcomes (KDIGO): Position statement on definition and classification of CKD &ndash; The debate should be about patient prognosis</a> (2009)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://c.ymcdn.com/sites/www.asdin.org/resource/resmgr/imported/ASDINVeinPreservation.pdf&amp;token=zSKJzI1/EbkG17kki2q/UpOYCwGlxLKozK5ODFm0IbS+UwnzTDJfAvZARPvmFRH2YAUwgfZQwBhwwhwN78gM1FSlXSiEsjBXxqElCeZndlB+MSe/PETYwhcfuAsb1SaJ&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">ASDIN and Association for Vascular Access (AVA): A position statement on guidelines for venous access in patients with chronic kidney disease</a> (2008)</p><p/><p class=\"headingAnchor\" id=\"H3343411839\"><span class=\"h1\">Europe</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/ndt/article/31/3/337/2460159/Recommendations-for-the-use-of-tolvaptan-in&amp;token=Vk1mPFEVkHAfNEpqrd3Wpg8YTbGPoOPLd5h0KRcOGx4BjvLPk1Th6rI3OUSk7YSo3gN7t0ZKHk0VYD1hLeEPdKeXA8rBZ1zXyM4V11mUb463hKFPbKlgmTcfwHRCNJPJ&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">European Renal Association (ERA)-European Dialysis and Transplant Association (EDTA): Position statement on recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/ndt/article/31/suppl_2/ii1/2414986/Clinical-Practice-Guideline-on-management-of-older&amp;token=+ACw15zNbQV1AL9LKjX68CjsIehxvRfYEAH+zkAkzGXZfnf9uWVoHbp6ni6Pt22eu6N9ooWcxk4yFb5CPD6dXDkyJuWH2geewy+JdXRTulauBqcpy+kwX0dfsr78OiSqHyL5PEWu1vYLtmpeFL6fIA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">European Renal Best Practice (ERBP): Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR &lt;45 mL/min/1.73 m2)</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/ndt/article/30/5/698/2332868/Should-patients-with-CKD-stage-5D-and-biochemical&amp;token=AG5j9RxOrZAZvWflpFSRb043imA9DSwbM1MRfbmkrK6DS1VDzMqwv7W1y748d3sJeZtVXSka9EQVcinTM1Ec20svMbIbyequIzGaWMy0myz75faT3QT5mb8Dtdg+sUvMU0LZxuMZmmhfa6F3jW4tFg==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">ERA-EDTA: Position statement &ndash; Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy?</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://academic.oup.com/ndt/article/30/suppl_2/ii1/2272478/Clinical-Practice-Guideline-on-management-of&amp;token=HFTgJGegnJf6B/EgtFZs42/uCrYBji9OQ37anl0cXPxgE86agK6GHmx0BNs96ddphrIHcCkWe9FWVdecQ2U4O33Holu6X6sG2DojjAixt3Lmbkwdo+R2Z9qOQ84le6bq+ZPeBJdMEDxqNFroFx9dhw==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">ERBP: Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR &lt;45 mL/min)</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.european-renal-best-practice.org/sites/default/files/u33/fabry2012.pdf&amp;token=gSpCLniqxHKwAsj+JpyY38xBmv4undSPmuP2DJOMSe/OKkbYAniTUjl/t5ENW1cKVfMMnprLCiM0UMhNsK/T13gpg204XuJCZVDASjC7LZk=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">ERBP: Fabry nephropathy &ndash; Indications for screening and guidance for diagnosis and treatment</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://espen.info/documents/0909/Adult+Renal+Failure.pdf&amp;token=UkqQPQpI7x15BicT71dSj6IVsaMdXbhPsszyE3J6kLzYwZXzE1qzlw1p4elU7eU7I7jeeW3xXNrO863SxxeohK8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">European Society for Clinical Nutrition and Metabolism (ESPEN): Guidelines on parenteral nutrition &ndash; Adult renal failure</a> (2009)</p><p/><p class=\"headingAnchor\" id=\"H3142984832\"><span class=\"h1\">United Kingdom</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/hst4/resources/migalastat-for-treating-fabry-disease-1394900887237&amp;token=0UXHHmBWmzJIpavsND6feDOhrfc/koA8I2+I87lYjFxH1bjosP81pbFS9oR+ldtHS/b+q1jd7+DD8ArpVj45T4vTat2ZqEoOyH2Q6Q+rVEKxzWUuqRRVN78XfT+XoEG7&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">National Institute for Health and Care Excellence (NICE): Highly specialised technologies guidance on migalastat for treating Fabry disease</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.clinexprheumatol.org/abstract.asp?a=10921&amp;token=NK91I08KOJ1eJ1hT1o/oHm8kgS7i2I/Go6Vi77BRHueuJNa7m54YGVVpYkMtWbtXBK3Mz41jVy9HBV8/j2qjFQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">UK Scleroderma Study Group (UKSSG): Guidelines on the diagnosis and management of scleroderma renal crisis</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/ta358/resources/tolvaptan-for-treating-autosomal-dominant-polycystic-kidney-disease-82602675026629&amp;token=a9Uw4rrarWUh7Z+sfyD0iJxpuXb/D0i9x9md1p6lURIzQc2qOjBrDmb16av/kIdFH+0N5b7X7htaIybxZGHnNDDyC75pBdR5c4DmgpGfLP9Thdm+mFzoBNzs672soLT6obio/yp/DOur4izmqMaFEfWyPYr2/rzI/VvwHdqCeAo=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NICE: Technology appraisal guidance on tolvaptan for treating autosomal dominant polycystic kidney disease</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg182/resources/chronic-kidney-disease-in-adults-assessment-and-management-35109809343205&amp;token=zoJ03fb9vS5gPx6CgNajqqgLY1mci+areRNqyew2sMPYOoOg0gSLqEjAyal8Zk340nXLXIoiE2S6xUYRUomzghdM3fQee1ilCjAT2gz5khrm8x+cUcXQcunq6umdtIkbmEQ5Jhb3MKtz4us85fr/DA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on chronic kidney disease in adults &ndash; Assessment and management</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/qs5/resources/chronic-kidney-disease-in-adults-58297746373&amp;token=ZzYVhD6e72UM0UdEGwgKGskajDjqvXS5Ex/1mMkRC/bWYAYglJCZDO9LQJNHrKYniF4gB42nrPAGD9xSzBZNQwDLQr67QUnR+47mGDkrJhq5XXFGdwGTv6v3uYOdvxIl&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NICE: Quality standard on chronic kidney disease in adults</a> (2011, updated 2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg157/resources/chronic-kidney-disease-stage-4-or-5-management-of-hyperphosphatemia-35109636340165&amp;token=cGqaNg9oqypYECQEM6LoODsGhkjiJem4rYfPK2YTK2nof15zwJFA3MoeQL4Dcr80T4rwY9ARGYRzTpiY8qhkV7X+ZQY2UTUGobmzW88qHtsW7x6HeGz+HnBI1eir23am9YPb6Lb7DrYLhm7WTOPV/xG63+5ptk287rcvs0KmGys=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on chronic kidney disease (stage 4 or 5) &ndash; Management of hyperphosphataemia</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.nice.org.uk/guidance/cg125/resources/chronic-kidney-disease-stage-5-peritoneal-dialysis-35109451582405&amp;token=Smg0+vwdukg5Td6MaRJN5NKyAktk5dVAMgBmfMSjteh1mBUUPqp7upb0QKywpVDuiT9d/sI6/L5Eo7YEO/wm7JwGRnTYKAEx55oZjIz0LMhavZSAtuUnxWBT2bWt7tbQbTAfIQNKa0ZpId91T2Bbmw==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">NICE: Clinical guideline on chronic kidney disease (stage 5) &ndash; Peritoneal dialysis</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.brit-thoracic.org.uk/document-library/clinical-information/tuberculosis/tb-guidelines/guidelines-in-adult-patients-with-tuberculosis-and-chronic-kidney-disease/&amp;token=JYkzG/dbKB5nID8xGIGg+opcmU2gLcHfGzbRyll544qifht9xomUF6yLTp5t1A49o+wUd6kgSIfK56hwNHb9XRvjknsaSuRaP+lwwUYFdhajrFcrZtvzVEh5y/g2XXShvKchST5g5FmAbFpZGZM3gr46y3JZNaSkPFqan6CWiBc=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">British Thoracic Society (BTS): Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease</a> (2010)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://journals.sagepub.com/doi/pdf/10.1177/0269216308100247&amp;token=9tdNMsd8D+j4Pmj33QmPSZQJh7+kJt1uC/hxzVvXznYDxoS48vWIcLEVVtvkxS22OLglxQzJgnBXzerxHdhvvuBF3eiiwErBSk8eWMszWPY=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Symptom management for the adult patient dying with advanced chronic kidney disease &ndash; A review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group</a> (2009)</p><p/><p class=\"headingAnchor\" id=\"H2263940355\"><span class=\"h1\">Australia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.racgp.org.au/your-practice/guidelines/redbook/&amp;token=MNgE/gzNwQ/ffOfYLJ0U2Z/akBdNRcLJJ+JLgHqWrYMpNAnyqhitmm6f2u66aQEXNgcYhhHaLe6djey2YXkSjw==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Royal Australian College of General Practitioners (RACGP): Guidelines for preventive activities in general practice, 9th edition</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://kidney.org.au/health-professionals/prevent/chronic-kidney-disease-management-handbook&amp;token=K3cMvlsCe4NAudFOzPJGBV+HlgbTy7RWPLzvF8q/u7HHjDWLpPEcGfDOdqykTY10Bys9rZcexvA/rt2wNaKyL6Aj5yNAzmD6FnL5CWEsowClONIyGQso0ekBAX8iQMpn&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Kidney Health Australia (KHA): Chronic kidney disease (CKD) management in general practice &ndash; Guidelines and clinical tips to help identify, manage and refer patients with CKD in your practice, 3rd edition</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cari.org.au/CKD/CKD+adpkd/ckd_adpkd.html&amp;token=A4rNrjoOj2Gkzpl8CyA25pfferRIhvyNrfCTw8fJ5Tsv0AMrnbFMrHntV26phWJsmQdUkfoUZfVSnBUNK6TLng==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KHA-Caring for Australasians with Renal Impairment (CARI): Chronic kidney disease guidelines &ndash; Autosomal dominant polycystic kidney disease</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.essa.org.au/wp-content/uploads/2015/10/ESSA-Position-Statement_Exercise-and-kidney-disease_23.01.2013.pdf&amp;token=6ABpMshdaVZUZTFpkKL6NrqDSGFm/pt8NkQ6fIImQ55NBZIqwi9JOwDjTg8t77AcFIQxY96wN5EcRByrJ1iQSbaj8rQkuFQ93Ki1loGqV8gAEv9D9En2SLh/vxwLVNYRMtOiTnOj+30/ovpA1FGmyq8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Exercise and Sports Science Australia (ESSA): Position statement on exercise and chronic kidney disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cari.org.au/CKD/CKD+cardiovascular+disease/ckd_cardiovascular_disease.html&amp;token=A4rNrjoOj2Gkzpl8CyA25tw/R747txTwRbTrfLB0Rv+UcsL7KgvpuGbCiYZJxPTHBiXoKi4iwqJPmjnZxUAxhm76d7ZFryqz1k485DZ2NFA=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KHA-CARI: Chronic kidney disease guidelines &ndash; Cardiovascular disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cari.org.au/CKD/CKD+early/ckd_early_ckd.html&amp;token=A4rNrjoOj2Gkzpl8CyA25j8oMHlocHW0a8dV7mvOzLd6vLUpXOr3ckyyhz/7ujL8ZxPafLG6tVUM4eLL9M6GhQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KHA-CARI: Chronic kidney disease guidelines &ndash; Early chronic kidney disease</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.mja.com.au/sites/default/files/issues/197_04_200812/joh11468_print_fm.pdf&amp;token=w4K+kBD5hWLK0lfHAVxWC6LSEODJShPoD3UpKP0XgN7KE5Lvf0+sIbPBWslJWYP+SUT7rKquffssQkzjQ++LvbkeOazsrbkuLdKNWaOnfsrZ98mMvDlOKM+JTkbZA8ih&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Guidelines on chronic kidney disease and measurement of albuminuria or proteinuria &ndash; A position statement</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.mja.com.au/system/files/issues/197_04_200812/joh11329_web_k_fm.pdf&amp;token=2TJ0ym8n9hnIe5LjuZcexBe9GaNWQf9/5gI/7Pf6joXOHQ/8DQioaWyeMnVHEKJqbjiPbzVCOkhDDNJjnqtq+fsy0X/bzW94c1clUXcyRjGvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Position statement on chronic kidney disease and automatic reporting of estimated glomerular filtration rate &ndash; New developments and revised recommendations</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.racgp.org.au/your-practice/guidelines/national-guide/&amp;token=nMah21vTKMGsekX0Wk//nTcar3RQ0G7+q/kM2NPOkcsODynpfRxdzz25fNUwDwrTKXJjV0aVk+ikSAjbBlT9uXuTInw1Y4kMcd5d6y5Q1xM=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">RACGP: National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people, 2nd edition</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cari.org.au/CKD/CKD+diabetes+type+2/ckd_diabetes_type_2.html&amp;token=A4rNrjoOj2Gkzpl8CyA25heFhmV+uOY+LqDk54Z8bE5dMpVs2sLnEwPVwJYnINl/gy5IwmvwqKvTOKfs7X1AnSqh4Fto5H3JDtvosFvcNQE=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KHA-CARI: Chronic kidney disease guidelines &ndash; Type 2 diabetes: Kidney disease</a> (2010)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/14d82dbb-d776-40c5-a848-9b22f251514e.pdf&amp;token=jVIIjbCTqWL9tPmZTlc7JB2kgbc+5XaBuVgJFwO0ABmgFUYZnBKHG5xdYRKVVt8NwMaKvap/REA/tb4jai6OoPjzbOuSE5IlNIeZFpnY9yufYo02U+iCggh3TdqkgV+H&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Diabetes Australia (DA): National evidence based guideline for diagnosis, prevention and management of chronic kidney disease in type 2 diabetes</a> (2009)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cari.org.au/CKD/CKD+vitamin+D/ckd_vitamin_d_etc.html&amp;token=A4rNrjoOj2Gkzpl8CyA25ghKK5t8iqLDoMaN5aPbDkUC2JSxWNgaMbDT6RoD7cPCjFjPtvt2iMscLN55ZKJJqQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">KHA-CARI: Chronic kidney disease guidelines &ndash; Vitamin D, calcimimetics and phosphate binders</a> (2006)</p><p/><p class=\"headingAnchor\" id=\"H1283231043\"><span class=\"h1\">Japan</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"http://cdn.jsn.or.jp/data/jsn-pregnancy.pdf&amp;token=+lM3QOA/956d2rKLcMAh/owi/bHqi5aqGTHbCklkBqzcSCOlnItdbJNgubxMfKK5bIYo6GkOCRbWU/+O8FXhOA==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Japanese Society of Nephrology (JSN): Clinical practice guidelines for the management of pregnancy in kidney disease patients</a> (2017)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"https://medicalnote.jp/contents/160523-003-TL&amp;token=i1p22liEzrFqjzpjae6upWBXJT7N3wYbU1M6EkV09E7DxLyw4QVyNQ8adkgmC//72NJg9LoFcASm5Ivf7YBqXQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Choosing Wisely Japan: About analgesics &ndash; Cases with heart disease/kidney disease</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In English] <a href=\"http://link.springer.com/article/10.1007/s10157-016-1334-0&amp;token=qK3nmCGytXVCEK0ez1+NnTYvYjRKbNnzRzaQc1R3IgE131DydkIrKz2mVufWL1adcJmR2fkWPdkPjxMEuu/qAK8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Clinical practice guideline for drug-induced kidney injury in Japan &ndash; Digest version</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"https://cdn.jsn.or.jp/guideline/pdf/2016-jsn-lifestyle-related-disease.pdf&amp;token=7mgKvS2/sepjJ6a5Zc9JH/gEagM+GUBqwYDkCImEh8yf95DbqMARwt+L1sCCS8L4hgUJ2X1sfswdvvTYWrRVJKR5uPMEl91v5XocRTIg4mM=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Recommendation for reduction of newly introduced dialysis patients from lifestyle-related diseases &ndash; Prevention, early detection, prevention of CKD (chronic kidney disease)</a> (2016)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In English] <a href=\"http://www.jsn.or.jp/en/guideline/pdf/PKD_eng.pdf&amp;token=LUlre2Rk71Qupk7gX7fI2+uyz/impn+dK4HRa/2K0GZsxxWV9TWK47BLizczpLqrMzAFrS6N6GcajHFYDjUqtg==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Evidence-based clinical practice guidelines for polycystic kidney disease, 2014</a> (published 2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"http://minds4.jcqhc.or.jp/minds/CKD_stageG3b-5/CKD_stageG3b-5_20151126.pdf&amp;token=mPe9uInOxVpiRiXYotfiEBs3nHoPDVSUHZTLr0kTLgXkOIEMpSzbVTuWi1BZSB7MH/cwDNB9hzyQR5lF47NrVK8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Ministry of Health, Labor, and Welfare (MHLW): CKD stage G3b-5 clinical practice guidelines for prevention of development of kidney disease in patients and smooth transition to renal replacement therapy</a> (2015)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"https://cdn.jsn.or.jp/guideline/pdf/CKD-Dietaryrecommendations2014.pdf&amp;token=iPUXJM9jd2c9r6ejMEDMYfEiXOysfDEoYmjgjv9248mq2yciuoUnv7NdhzRLHj3OwntxfzFjmKHKEmk8OiOCWtBYIWbJNxZelNPBPVgObX4=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Diet therapy standards for chronic kidney disease</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"https://cdn.jsn.or.jp/guideline/pdf/PKD_141023.pdf&amp;token=8OcTO9jVb3T1LWQxkTVDGEF7wGyi/Qhh5e7ZVnf51Cq7k/vhNdVJAwTQDGZKRpsWWBL/fB7WHcuPjPvdks330w==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Evidence based polycystic kidney disease (PKD) clinical practice guideline</a> (2014)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"http://cdn.jsn.or.jp/guideline/pdf/CKD_evidence2013/all.pdf&amp;token=+lM3QOA/956d2rKLcMAh/pv3ElmSMd9zZSgXaX7A3OXHGsnpL/9fv4CTS4s+8Z8S0Ie4zh4Ejh0cBiF7HpBWZq8AtSQsFLDSFqHlsS1NKKs=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Evidence-based clinical practice guideline for CKD</a> (2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In English] <a href=\"https://link.springer.com/article/10.1007%2Fs10157-013-0843-3&amp;token=3vrciaU7tEygqhBjxqbz3ECTrPvFYppfr0WHOx60olIuvSZwu7jz0H+3MmTArn0pmHZyL/5XdO9cORblz9JaKdW8oTdgp9HQ8KJzsxI/p8g=&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN, Japan Radiological Society (JRS), and Japanese Circulation Society (JCS): Guidelines on the use of iodinated contrast media in patients with kidney disease 2012 &ndash; Digest version</a> (published 2013)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In Japanese] <a href=\"https://cdn.jsn.or.jp/guideline/pdf/CIN_2012.pdf&amp;token=8OcTO9jVb3T1LWQxkTVDGEF7wGyi/Qhh5e7ZVnf51CriWpzOuXx5rPraXQtqg8BdQav8ZO2q3MhvAZ6I9qu5VQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN, JRS, JCS: Guideline on the use of iodine contrast agent in renal disorder patients</a> (2012)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In English] <a href=\"http://www.jsn.or.jp/academicinfo/ckd/AFCKDI2011.pdf&amp;token=LUlre2Rk71Qupk7gX7fI219fBXGqrMH8LOBCzR573KhU+Cyzlf+iDr7Y2hkunbJ01tW/Pdx9T6lZvq0Baww8gQ==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">Asian Forum for Chronic Kidney Disease Initiative (AFCKDI): Asian chronic kidney disease best practice recommendations &ndash; Positional statement for early detection of chronic kidney disease</a> (2011)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>[In English] <a href=\"http://www.jsn.or.jp/en/guideline/pdf/guideline2009.pdf&amp;token=LUlre2Rk71Qupk7gX7fI2+uyz/impn+dK4HRa/2K0GYvHjd+1T0fgr56b0eNtuiicWdClRU4EWngLH+33Wijzw==&amp;TOPIC_ID=110749\" target=\"_blank\" class=\"external\">JSN: Evidence-based clinical practice guideline for the treatment of chronic kidney disease</a> (2009)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"topicVersionRevision\">Topic 110749 Version 3.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li><a href=\"#H1734429721\" id=\"outline-link-H1734429721\">Introduction</a></li><li><a href=\"#H934096855\" id=\"outline-link-H934096855\">International</a></li><li><a href=\"#H3247897960\" id=\"outline-link-H3247897960\">Canada</a></li><li><a href=\"#H1322772545\" id=\"outline-link-H1322772545\">United States</a></li><li><a href=\"#H3343411839\" id=\"outline-link-H3343411839\">Europe</a></li><li><a href=\"#H3142984832\" id=\"outline-link-H3142984832\">United Kingdom</a></li><li><a href=\"#H2263940355\" id=\"outline-link-H2263940355\">Australia</a></li><li><a href=\"#H1283231043\" id=\"outline-link-H1283231043\">Japan</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-anemia-in-chronic-kidney-disease\" class=\"medical medical_society_guidelines\">Society guideline links: Anemia in chronic kidney disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-chronic-kidney-disease-in-children\" class=\"medical medical_society_guidelines\">Society guideline links: Chronic kidney disease in children</a></li></ul></div></div>","javascript":null}